TScan is a Massachusetts-based biopharmaceutical company that develops and commercializes T-cell therapies for the treatment of cancer.
Business Model:
Revenue: $13.3M
Employees: 51-200
Address: 830 Winter Street
City: Waltham
State: MA
Zip: 02451
Country: US
TScan is a Massachusetts-based biopharmaceutical company that develops and commercializes T-cell therapies for the treatment of cancer.
Contact Phone:
+18573999500
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/15/2021
IPO Valuation:
$359M
Ticker Symbol:
TCRX
IPO Price:
$15/share
Amount Raised:
$100M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|